Key Drivers
- Liquidity cushion
- Heavy leverage
- Cash burn
AIAI Summary
NBTX should now be viewed primarily as a financing-and-catalyst trade: the Euronext Tech Leaders listing and recent equity raise improve visibility and runway, but the investment case hinges on management converting that capital into clear late-stage de-risking before another dilutive financing is needed.
Price Chart
Financial Metrics
Deep Analysis
Research tool. Not personalized advice.
Fundamental Analysis
Key Financial Insights:
- •Liquidity cushion
- •Heavy leverage
- •Cash burn
NBTX has modest near-term liquidity and a sizable deferred-revenue base, but its highly leveraged balance sheet, persistent losses, and negative free cash flow keep the investment case weak.
Price Behavior
Key Price Behavior Insights:
- •Range Bound
- •Key Support
- •Clear Resistance
NBTX has been range-bound and slightly weaker over the last month, with $37-$38 holding as support, $40.20-$40.40 acting as resistance, and a breakout above the low-40s needed to improve the setup.
Sharp drop to $35.73 followed by a quick rebound above $40
Sentiment & News
Key News Insights:
- •Ownership disclosure
- •Capital structure
- •Regulatory filing
NBTX disclosed an administrative update to its voting rights and share capital, reinforcing regulatory compliance and transparency around its ownership structure.
This update is likely neutral for the stock, with limited direct impact beyond maintaining governance and disclosure transparency
Similar Companies in Healthcare
Other companies in the same sector with AI ratings